DDX5-Targeting Fragile X Mental Retardation Protein Regulates the Wnt/β-catenin Signaling Pathway to Promote Epithelial Mesenchymal Transition in Breast Cancer

CAO Jia, WANG Jing, SHI Bin, MA Xiaolan, WU Weichao, WANG Nan

Abstract

To investigate the role of fragile X mental retardation protein (FMRP) in promoting cell migration and epithelial-mesenchymal transition (EMT) in breast cancer (BC) and the potential mechanisms involved.

Methods 

The mRNA and protein expressions of FMRP in MCF-10A, a normal human breast epithelial cell line, and four breast cancer cell lines, including MCF-7, BT474, MDA-MB-231, and HCC1937, were analyzed by RT-PCR and Western blot. The expression of FMRP in BC tissues was measured by immunohistochemistry (IHC). FMRP expression in BC and its relationship with clinical prognosis were analyzed using GEO database. Lentiviral infection and siRNA interference were used to construct FMRP overexpression and interference vectors, respectively, and the human breast cancer cell line MCF-7 was subsequently transfected. A Control group, an interference empty vector group (the NC group), a knockdown vector group (the siFMRP group), an overexpression empty vector group (the Lv-NC group), and an overexpression vector group (the Lv-FMRP group) were set up. The migration and invasion abilities of the cells were assessed by scratch assay and Transwell assay. The expression of EMT markers, including E-cadherin, an epithelial marker, N-cadherin, an mesenchymal markers, vimentin, zinc finger E-box binding homeobox 1 (ZEB1), and snail family zinc finger 2 (Slug), in the cells of each group was determined by Western blot. The interaction between FMRP and DEAD-box RNA helicase-5 (DDX5) protein was analyzed by immunocoprecipitation combined with mass spectrometry (IP-MS). The regulatory effect of FMRP on DDX5 protein expression was assessed using the protein synthesis inhibitor cycloheximide (CHX) and proteasome inhibitor MG132. In addition, transfection with siDDX5 vector was conducted to observe whether DDX5 could reverse the effects of FMRP overexpression on cell migration and EMT. The localization and expression of β-catenin were determined by immunofluorescence staining, and the expression of core markers of Wnt/β-catenin signaling pathway was examined by Western blot.

Results 

FMRP was highly expressed in BC tissues and cells (P<0.05), and overall survival (OS) and recurrence-free survival (RFS) of the FMRP high expression group were significantly lower than those of the FMRP low expression group (P<0.05). The migration ability of MCF-7 cells was weakened after FMRP knockdown, while overexpression of FMRP promoted cell migration (P<0.05). After FMRP knockdown, the expression of E-cadherin was increased, while the expression levels of N-cadherin, vimentin, ZEB1, and Slug were decreased, which inhibited the occurrence of EMT. In contrast, the overexpression of FMRP promoted the EMT process (P<0.05). FMRP interacted with DDX5 protein and promoted DDX5 protein stability by blocking the ubiquitin-proteasome pathway. DDX5 knockdown reversed the effect of FMRP overexpression to promote cell migration and EMT (P<0.05), effectively inhibited β-catenin nuclear translocation, and decreased β-catenin nuclear distribution. Furthermore, it was found that the expression of p-β-catenin, GSK3β and Axin2 protein was increased and the expression of C-myc protein was decreased after DDX5 downregulation (P<0.05). On the other hand, the expression of these proteins was reversed by combined FMRP overexpression (P<0.05).

Conclusion 

FMRP targets DDX5 and promotes BC cell migration and EMT via the activation of the Wnt/β-catenin signaling pathway.

 

Keywords: FMRP, DDX5, EMT, Wnt/β-catenin signal pathway, Breast cancer

 

Full Text:

PDF


References


SIEGEL R L, GIAQUINTO A N, JEMAL A. Cancer statistics, 2024. CA Cancer J Clin, 2024, 74(1): 12–49. doi: 10.3322/caac.21820.

SUNG H, FERLAY J, SIEGEL R L, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209–249. doi: 10. 3322/caac.21660.

LEVEY N, KRISHNA I. Breast cancer in pregnancy: caring for the very young breast cancer patient from diagnosis through survivorship. Obstet Gynecol Clin North Am, 2022, 49(1): 181–193. doi: 10.1016/j.ogc.2021.11. 006.

ZHENG H, AN M, LUO Y, et al. PDGFRα+ITGA11+ fibroblasts foster early-stage cancer lymphovascular invasion and lymphatic metastasis via ITGA11-SELE interplay. Cancer Cell, 2024, 42(4): 682–700. e12. doi: 10.1016/j.ccell.2024.02.002.

JIANG C, ZHANG N, HU X, et al. Tumor-associated exosomes promote lung cancer metastasis through multiple mechanisms. Mol Cancer, 2021, 20(1): 117. doi: 10.1186/s12943-021-01411-w.

BRACKEN C P, GOODALL G J, GREGORY P A. RNA regulatory mechanisms controlling TGF-β signaling and EMT in cancer. Semin Cancer Biol, 2024, 102-103: 4–16. doi: 10.1016/j.semcancer.2024.06.001.

FENG X, YIN Z, OU S, et al. The anti-tumor effects of Celastrus orbiculatus Thunb. and its monomer composition: a review. J Ethnopharmacol, 2023, 310: 116363. doi: 10.1016/j.jep.2023.116363.

ZHU X, HAN S, WU S, et al. Dual role of twist1 in cancer-associated fibroblasts and tumor cells promoted epithelial-mesenchymal transition of esophageal cancer. Exp Cell Res, 2019, 375(2): 41–50. doi: 10.1016/j. yexcr.2019.01.002.

ZHANG C Y, LI R K, QI Y, et al. Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial–mesenchymal transition. Cell Biol Toxicol, 2016, 32(5): 391–401. doi: 10.1007/s10565-016-9341-1.

THAR Y M, JOSEPH S. ATHAR Y M, et al. RNA-binding specificity of the human fragile X mental retardation protein. J Mol Biol, 2020, 432(13): 3851–3868. doi: 10.1016/j.jmb.2020.04.021.

LI M, SHIN J, RISGAARD R D, et al. Identification of FMR1-regulated molecular networks in human neurodevelopment. Genome Res, 2020, 30(3): 361–374. doi: 10.1101/gr.251405.119.

ZALFA F, PANASITI V, CAROTTI S, et al. The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cells. Cell Death Dis, 2017, 8: e3169. doi: 10.1038/cddis.2017. 521.

ZHU Y J, ZHENG B, LUO G J, et al. Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinoma. Theranostics, 2019, 9(12): 3526–3540. doi: 10. 7150/thno.32796.

HU Y, GAO Q, MA S, et al. FMR1 promotes the progression of colorectal cancer cell by stabilizing EGFR mRNA in an m6A-dependent manner. Cell Death Dis, 2022, 13(11): 941. doi: 10.1038/s41419-022-05391-7.

WANG N, SHI B, MA X L, et al. High expression of fragile X mental retardation protein inhibits ferroptosis of colorectal tumor cells by activating the RAS/MAPK signaling pathway. J Southern Med Univ, 2024, 44(5): 885–893 doi: 10.12122/j.issn.1673-4254.2024.05.10.

SHIN S, ROSSOW K L, GRANDE J P, et al. Involvement of RNA helicases p68 and p72 in colon cancer. Cancer Res, 2007, 15;67(16): 7572–7578. doi: 10.1158/0008-5472.CAN-06-4652.

D'ANTONI S, SPATUZZA M, BONACCORSO C M, et. al. Role of fragile X messenger ribonucleoprotein 1 in the pathophysiology of brain disorders: a glia perspective. Neurosci Biobehav Rev, 2024, 162: 105731. doi: 10.1016/j.neubiorev.2024.105731.

LUCÁ R, AVERNA M, ZALFA F, et al. The fragile Xprotein binds mRNAs involved in cancer progression and modulates metastasis formation. EMBO Mol Med, 2013, 5: 1523–1536. doi: 10.1002/emmm. 201302847.

PASCIUTO E, BAGNI C. SnapShot: FMRP mRNA targets and diseases. Cell, 2014, 158(6): 1446-1446. e1. doi: 10.1016/j.cell.2014.08.035.

JACOB J, FAVICCHIO R, KARIMIAN N, et al. LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5. Cancer Lett, 2016, 372(1): 137–146. doi: 10.1016/j.canlet.2015.12.026.

LI F, LING X, CHAKRABORTY S, et al. Role of the DEAD-box RNA helicase DDX5 (p68) in cancer DNA repair, immune suppression, cancer metabolic control, virus infection promotion, and human microbiome (microbiota) negative influence. J Exp Clin Cancer Res, 2023, 42(1): 213. doi: 10.1186/s13046-023-02787-x.

CAUSEVIC M, HISLOP R G, KERNOHAN N M, et al. Overexpression and poly-ubiquitylation of the DEAD-box RNA helicase p68 in colorectal tumours. Oncogene, 2001, 20(53): 7734–7743. doi: 10.1038/sj.onc. 1204976.

HAN F Y , XING Y , Ll Y, et al. DDX5 promotes invasion of human breast cancer cells through epithelial-mesenchymal transition. Prog Anat Sci, 2023, 29(5): 459–461. doi: 10.16695/j.cnki.1006-2947.2023.05.004.

TANG Z, YANG Y, CHEN W, et al. Epigenetic deregulation of MLF1 drives intrahepatic cholangiocarcinoma progression through EGFR/AKT and Wnt/β-catenin signaling. Hepatol Commun, 2023, 7(8): e0204. doi: 10.1097/HC9.0000000000000204.

XUE W, YANG L, CHEN C, et al. Wnt/β-catenin-driven EMT regulation in human cancers. Cell Mol Life Sci, 2024, 81(1): 79. doi: 10.1007/s00018-023-05099-7.

WANG J, CAI H, LIU Q, et al. Cinobufacini inhibits colon cancer invasion and metastasis via suppressing Wnt/β-catenin signaling pathway and EMT. Am J Chin Med, 2020, 48(3): 703–718. doi: 10.1142/S0192415X20500354.


Refbacks

  • There are currently no refbacks.